Related references
Note: Only part of the references are listed.Chromosome Instability Accounts for Reverse Metastatic Outcomes of Pediatric and Adult Synovial Sarcomas
Pauline Lagarde et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cediranib for Metastatic Alveolar Soft Part Sarcoma
Shivaani Kummar et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
A. Gronchi et al.
ANNALS OF ONCOLOGY (2012)
Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC-STBSG
Syvie Bonvalot et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor A Randomized Trial
Heikki Joensuu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T. A. van der Graaf et al.
LANCET (2012)
Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissues sarcomas
Ruiz-Soto Rodrigo et al.
EUROPEAN JOURNAL OF CANCER (2011)
Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database
A. Italiano et al.
ANNALS OF ONCOLOGY (2010)
Extremity Soft Tissue Sarcoma in a Series of Patients Treated at a Single Institution Local Control Directly Impacts Survival
Alessandro Gronchi et al.
ANNALS OF SURGERY (2010)
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
Piotr Rutkowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
David Thomas et al.
LANCET ONCOLOGY (2010)
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
Frederic Chibon et al.
NATURE MEDICINE (2010)
Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control
Sylvie Bonvalot et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
Ronald P. DeMatteo et al.
LANCET (2009)
Adjuvant Chemotherapy in Localized Soft Tissue Sarcomas: Still Not Proven
Jean-Yves Blay et al.
ONCOLOGIST (2009)
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
Nabeel Pervaiz et al.
CANCER (2008)
Medical progress: Soft-tissue sarcomas in adults
MA Clark et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
J Verweij et al.
LANCET (2004)
Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes
JN Cormier et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy
JY Blay et al.
EUROPEAN JOURNAL OF CANCER (2003)
Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma
R Petrioli et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial
S Frustaci et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
